At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
Patients not treatedother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Lipoprotein Lipidic Composition, Lipopolysaccharide Binding Protein, and Bacterial Endotoxin Exposure in Parkinson's Disease: A Pilot Study
In Brief
An observational study evaluating Patients not treated for Parkinson Disease. Completed, enrolled 45 participants across 1 site.
Detailed Summary
Patients with Parkinson's disease (PD) present an impaired intestinal permeability with consequent lipopolysaccharide (LPS) translocation in the systemic circulation. Plasmatic lipoproteins play a key role in the detoxification of LPS. The investigators aim to study the relationships between lipoprotein chemical composition and plasma LPS circulation in PD.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesItaly
CollaboratorsIstituti Clinici di Perfezionamento di Milano
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMay 2016
Primary CompletionOct 2017
First PostedMay 2019
TodayJul 2026
First PostedMay 3, 2019
Enrollment StartMay 3, 2016
Primary CompletionOct 20, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 7.2 years ago
Interventions
Patients not treatedother